SBC Medical Group Appoints Renowned Plastic Surgery Expert Dr. Steven R. Cohen as Medical Strategy Advisor to Drive Global Expansion
SBC Medical Group Appoints Renowned Plastic Surgery Expert Dr. Steven R. Cohen as Medical Strategy Advisor to Drive Global Expansion SBC Medical Group Holdings (headquarters: California, USA; CEO: Yoshiyuki Aikawa) is pleased to announce that Dr. Steven R. Cohen, a…
AdventHealth and Anthem Blue Cross Blue Shield of Georgia Ink Multi-Year Deal to Broaden Access to Quality Care in Northwest Georgia
AdventHealth and Anthem Blue Cross Blue Shield of Georgia Ink Multi-Year Deal to Broaden Access to Quality Care in Northwest Georgia AdventHealth and Anthem Blue Cross Blue Shield of Georgia (Anthem) are pleased to announce a new multi-year contractual agreement…
HistoSonics Secures Expanded Insurance Coverage for Liver Tumor Therapy, Reaching 7 Million Highmark Blue Cross Blue Shield Members
HistoSonics , maker of the Edison® Tissue Ablation System , today announced that Highmark Blue Cross Blue Shield has issued four new positive medical policy decisions for the use of Tissue Ablation technology in the treatment of liver tumors. The decisions expand…
Elegen and Nutcracker Therapeutics to Pilot First Fully Cell-Free Process for Personalized RNA Cancer Therapies
Elegen , a leading next-generation DNA manufacturer, and Nutcracker Therapeutics , a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot program to demonstrate the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer therapeutics…
CEL-SCI to Partner With Leading Saudi Pharma Firm to Advance Multikine for Head and Neck Cancer Treatment
CEL-SCI to Partner With Leading Saudi Pharma Firm to Advance Multikine for Head and Neck Cancer Treatment Today announced it has reached an agreement with one of Saudi Arabia’s premier pharmaceutical and healthcare companies for a partnership that spans regulatory…
Elegen and Nutcracker Therapeutics Launch Pilot of First Fully Cell-Free Manufacturing Process for Personalized RNA Cancer Therapies
A global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot program to demonstrate the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer…
Parse Technology-Powered Research Maps Neuronal Pathways, Advancing Neurodegenerative Disease Insights
Parse Biosciences, a leading provider of easy-to-use and scalable single-cell sequencing solutions, today announced that a groundbreaking study published in Science used Parse’s single-cell technology to reveal how signaling pathways drive the formation of multiple neuronal subtypes. By linking specific signals to cell fate…
Artificial Intelligence in Clinics Set to Transform Diagnostic Practices – ResearchAndMarkets.com
Artificial Intelligence in Clinics Set to Transform Diagnostic Practices – ResearchAndMarkets.com Smart In-Vitro Diagnostics Market Report Highlights the Growing Role of AI in Healthcare New report from ResearchAndMarkets.com explores how artificial intelligence is transforming the in-vitro diagnostics (IVD) industry. A…
iFIT Teams Up with Samsung Health to Offer Personalized Fitness and Wellness Experiences Globally
iFIT Teams Up with Samsung Health to Offer Personalized Fitness and Wellness Experiences Globally iFIT, a global leader in connected fitness devices and interactive content, today announced a groundbreaking partnership with Samsung Health, one of the most trusted names in…
Personalis Expands Tempus Partnership to Deliver Ultra-Sensitive Recurrence Testing for Colorectal Cancer
Personalis Expands Tempus Partnership to Deliver Ultra-Sensitive Recurrence Testing for Colorectal Cancer Today announced an expansion and extension of its strategic collaboration with Tempus AI, Inc. (Nasdaq: TEM), adding a new indication, colorectal cancer (CRC), to the existing, exclusive commercialization…
CyPath® Lung Identifies Stage 1A Lung Cancer in High-Risk Patient Despite Inconclusive Imaging
BioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company addressingthe need for noninvasive, accurate tests for the detection of early-stage cancer, today released a new case study of a complex clinical case in which CyPath® Lung identified Stage 1A adenocarcinoma lung cancer in…
KVC Health Systems and WellSky® Partner to Improve Behavioral Health Care
KVC Health Systems and WellSky® Partner to Improve Behavioral Health Care WellSky, a global health and community care technology and services company, today announced that KVC Health Systems, a national leader in mental health, child welfare, and health and human services…